International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers

Alberto Biggi; Andrea Gallamini; Stephane Chauvie; Martin Hutchings; Lale Kostakoglu; Michele Gregianin; Michel Meignan; Bogdan Malkowski; Michael S Hofman; Sally F Barrington

doi:10.2967/jnumed.112.110890

International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers

Alberto Biggi, Andrea Gallamini, Stephane Chauvie, Martin Hutchings, Lale Kostakoglu, Michele Gregianin, Michel Meignan, Bogdan Malkowski, Michael S Hofman, Sally F Barrington

Research output: Contribution to journal › Article › peer-review

258 Citations (Scopus)

Abstract

At present, there are no standard criteria that have been validated for interim PET reporting in lymphoma. In 2009, an international workshop attended by hematologists and nuclear medicine experts in Deauville, France, proposed to develop simple and reproducible rules for interim PET reporting in lymphoma. Accordingly, an international validation study was undertaken with the primary aim of validating the prognostic role of interim PET using the Deauville 5-point score to evaluate images and with the secondary aim of measuring concordance rates among reviewers using the same 5-point score. This paper focuses on the criteria for interpretation of interim PET and on concordance rates.

Original language	English
Pages (from-to)	683-90
Number of pages	8
Journal	Journal of Nuclear Medicine
Volume	54
Issue number	5
DOIs	https://doi.org/10.2967/jnumed.112.110890
Publication status	Published - May 2013

Access to Document

10.2967/jnumed.112.110890

Cite this

Biggi, A., Gallamini, A., Chauvie, S., Hutchings, M., Kostakoglu, L., Gregianin, M., Meignan, M., Malkowski, B., Hofman, M. S., & Barrington, S. F. (2013). International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers. Journal of Nuclear Medicine, 54(5), 683-90. https://doi.org/10.2967/jnumed.112.110890

@article{c108f8267cb4458caee3d1988ef3f855,

title = "International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers",

abstract = "At present, there are no standard criteria that have been validated for interim PET reporting in lymphoma. In 2009, an international workshop attended by hematologists and nuclear medicine experts in Deauville, France, proposed to develop simple and reproducible rules for interim PET reporting in lymphoma. Accordingly, an international validation study was undertaken with the primary aim of validating the prognostic role of interim PET using the Deauville 5-point score to evaluate images and with the secondary aim of measuring concordance rates among reviewers using the same 5-point score. This paper focuses on the criteria for interpretation of interim PET and on concordance rates.",

author = "Alberto Biggi and Andrea Gallamini and Stephane Chauvie and Martin Hutchings and Lale Kostakoglu and Michele Gregianin and Michel Meignan and Bogdan Malkowski and Hofman, {Michael S} and Barrington, {Sally F}",

year = "2013",

month = may,

doi = "10.2967/jnumed.112.110890",

language = "English",

volume = "54",

pages = "683--90",

journal = "Journal of Nuclear Medicine",

issn = "1535-5667",

publisher = "Society of Nuclear Medicine and Molecular Imaging",

number = "5",

}

Biggi, A, Gallamini, A, Chauvie, S, Hutchings, M, Kostakoglu, L, Gregianin, M, Meignan, M, Malkowski, B, Hofman, MS & Barrington, SF 2013, 'International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers', Journal of Nuclear Medicine, vol. 54, no. 5, pp. 683-90. https://doi.org/10.2967/jnumed.112.110890

TY - JOUR

T1 - International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma

T2 - Interpretation Criteria and Concordance Rate Among Reviewers

AU - Biggi, Alberto

AU - Gallamini, Andrea

AU - Chauvie, Stephane

AU - Hutchings, Martin

AU - Kostakoglu, Lale

AU - Gregianin, Michele

AU - Meignan, Michel

AU - Malkowski, Bogdan

AU - Hofman, Michael S

AU - Barrington, Sally F

PY - 2013/5

Y1 - 2013/5

N2 - At present, there are no standard criteria that have been validated for interim PET reporting in lymphoma. In 2009, an international workshop attended by hematologists and nuclear medicine experts in Deauville, France, proposed to develop simple and reproducible rules for interim PET reporting in lymphoma. Accordingly, an international validation study was undertaken with the primary aim of validating the prognostic role of interim PET using the Deauville 5-point score to evaluate images and with the secondary aim of measuring concordance rates among reviewers using the same 5-point score. This paper focuses on the criteria for interpretation of interim PET and on concordance rates.

AB - At present, there are no standard criteria that have been validated for interim PET reporting in lymphoma. In 2009, an international workshop attended by hematologists and nuclear medicine experts in Deauville, France, proposed to develop simple and reproducible rules for interim PET reporting in lymphoma. Accordingly, an international validation study was undertaken with the primary aim of validating the prognostic role of interim PET using the Deauville 5-point score to evaluate images and with the secondary aim of measuring concordance rates among reviewers using the same 5-point score. This paper focuses on the criteria for interpretation of interim PET and on concordance rates.

U2 - 10.2967/jnumed.112.110890

DO - 10.2967/jnumed.112.110890

M3 - Article

C2 - 23516309

SN - 1535-5667

VL - 54

SP - 683

EP - 690

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

IS - 5

ER -

International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers

Abstract

Access to Document

Fingerprint

Cite this